Back to article: Could TNF-antagonists be a novel treatment strategy for BPH patients?

FIGURE 1: Model indicating the cellular changes in BPH compared to the normal prostate. Chronic inflammation is present in the prostates of many BPH patients, where anti-inflammatory therapies, such as TNF-antagonists, may be beneficial.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.